Comera Life Sciences Holdings, Inc. Share Price
Equities
CMRA
US20037C1080
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 USD | -16.90% | -26.83% | -45.45% |
01-30 | Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes | CI |
01-30 | Comera Life Sciences Holdings, Inc. Announces Changes to Its Board | CI |
Sales 2021 | 320K 25.48M | Sales 2022 | 633K 50.44M | Capitalization | 24.41M 1.95B |
---|---|---|---|---|---|
Net income 2021 | -5M -398M | Net income 2022 | -18M -1.43B | EV / Sales 2021 | 400 x |
Net cash position 2021 | 6.19M 493M | Net Debt 2022 | 328K 26.17M | EV / Sales 2022 | 39.1 x |
P/E ratio 2021 |
-7.26
x | P/E ratio 2022 |
-0.7
x | Employees | 13 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 29.53% |
1 day | -16.90% | ||
1 week | -26.83% | ||
Current month | -11.76% | ||
1 month | -11.76% | ||
3 months | -52.83% | ||
6 months | -90.00% | ||
Current year | -45.45% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Campbell
CEO | Chief Executive Officer | - | 12/04/22 |
Corporate Officer/Principal | - | 08/11/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stuart Randle
BRD | Director/Board Member | 64 | 18/05/22 |
James Sherblom
BRD | Director/Board Member | 68 | 31/12/20 |
Director/Board Member | 48 | 18/05/22 |
Date | Price | Change | Volume |
---|---|---|---|
02/05/24 | 0.03 | -16.90% | 41,072 |
01/05/24 | 0.0361 | -9.75% | 58,916 |
30/04/24 | 0.04 | +10.80% | 2,250 |
26/04/24 | 0.0361 | 0.00% | 267 |
25/04/24 | 0.0361 | -11.95% | 134,565 |
Delayed Quote OTC Markets, May 02, 2024 at 06:39 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-45.45% | 1.11M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- CMRA Stock